KSS
39
-7
SJM
9
-5
HAL
48
-3
MTCH
20
-8
MU
28
-3
RHI
57
-6
JNPR
50
-6
TXT
53
-3
EXR
57
2
MCHP
34
-2
CTAS
53
-3
CRM
60
-7
NVDA
52
-5
BXP
49
-3
STX
45
-4
CNP
54
10
K
51
-3
ILMN
32
-9
KEY
43
-3
CSX
57
-4
KSS
39
-7
SJM
9
-5
HAL
48
-3
MTCH
20
-8
MU
28
-3
RHI
57
-6
JNPR
50
-6
TXT
53
-3
EXR
57
2
MCHP
34
-2
CTAS
53
-3
CRM
60
-7
NVDA
52
-5
BXP
49
-3
STX
45
-4
CNP
54
10
K
51
-3
ILMN
32
-9
KEY
43
-3
CSX
57
-4
Financhill
Back

Protagonist Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
26

PTGX
Protagonist Therapeutics

Last Price:
41.14
Seasonality Move:
12.96%
Sell
33

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
26
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.11. The Score for PTGX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 31.67 Sell
Chaikin Money Flow: 434003 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.11 - 48.03) Sell
Bollinger Bands (100): (37.47 - 46.31) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: -8154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Buy
Bollinger Bands (100): (0.27 - 1.57) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.49 Sell
20-day SMA: 45.93 Sell
50-day SMA: 45.52 Sell
200-day SMA: 35.41 Buy
8-day EMA: 43.6 Sell
20-day EMA: 45.02 Sell
50-day EMA: 44.54 Sell
200-day EMA: 36.64 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.68 Buy
50-day SMA: 0.64 Buy
200-day SMA: 2.44 Sell
8-day EMA: 0.72 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.82 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):